---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-037078"
form_type: "8-K"
ticker: "VCNX"
cik: "0001205922"
company_name: "VACCINEX, INC."
filed_at: "2024-02-15T23:59:59+00:00"
generated_at: "2026-06-06T00:48:33.285461+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Vaccinex implements 1-for-14 reverse stock split to regain Nasdaq minimum bid price compliance

## Summary
- Split effective 5:00 p.m. ET Feb 19, 2024; shares trade split-adjusted from Feb 20.
- Ratio 1-for-14, approved by board and stockholders; new CUSIP 918640301.
- Complying with $1.00 minimum bid price required by Nasdaq by March 4, 2024.
- Fractional shares rounded up; authorized shares unchanged; equity awards adjusted.
- Shares continue trading under symbol VCNX; transfer agent is Computershare.

## SEC filing metadata
- accession: 0001193125-24-037078
- form_type: 8-K
- ticker: VCNX
- cik: 0001205922
- company_name: VACCINEX, INC.
- filed_at: 2024-02-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1205922/000119312524037078/0001193125-24-037078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1205922/000119312524037078/d754295d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-037078
- JSON: https://secwatch.observer/filing/0001193125-24-037078.json
- Plain text: https://secwatch.observer/filing/0001193125-24-037078.txt

## Key facts
- Governance Changes
  VACCINEX, INC.: Implemented a 1-for-14 reverse stock split of the Company's issued common stock, effective at 5:00 p.m. Eastern Time on February 19, 2024, via a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective 2024-02-19).
  - Change: charter amendment
  - Effective: 2024-02-19
  source text: On February 14, 2024, Vaccinex, Inc. (the “Company”) filed a Certificate of Amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Delaware Secretary of State to implement a reverse stock split of the Company’s issued shares of common stock at a ratio of 1-for-14, effective at 5:00 p.m. Eastern Time on Monday February 19, 2024 (the “Reverse Stock Split”), previously approved by the Company’s Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1205922/000119312524037078/0001193125-24-037078-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.